Detection of ductal carcinoma in situ and subsequent interval cancers: Recent paper provides lessons for smarter screening

BMJ (Online)

Volumn 352, Issue , 2016, Pages

  Shieh, Yiwey ^a   Eklund, Martin ^b   Esserman, Laura ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER SCREENING; CANCER THERAPY; EARLY DIAGNOSIS; EDITORIAL; HUMAN; INTERVAL BREAST CANCER; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; PRIORITY JOURNAL; RADIOLOGIST; UNITED KINGDOM; UNITED STATES; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; RADIOGRAPHY;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS;

EID: 84973503029     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i551     Document Type: Editorial

References (13)

1. Duffy SW, Dibden A, Michalopoulos D, et al. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: A retrospective population-based study. Lancet Oncol 2016; 17: 109-14. doi: 10.1016/S1470-2045(15) 00446-5. 26655422.
2. Liston J, Wilson R. Clinical guidelines for breast cancer screening assessment. NHSBSP, 2010.
3. Oeffinger KC, Fontham ETH, Etzioni R, et al. American Cancer Society. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA 2015; 314: 1599-614. doi: 10.1001/jama.2015.12783. 26501536.
4. Siu AL. US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2016 Jan 12 [Epub ahead of print]. doi: 10.7326/M15-2886. 26757170.
5. Esserman L, Cowley H, Eberle C, et al. Improving the accuracy of mammography: Volume and outcome relationships. J Natl Cancer Inst 2002; 94: 369-75. doi: 10.1093/jnci/94.5. 369. 11880475.
6. Smith-Bindman R, Chu PW, Miglioretti DL, et al. Comparison of screening mammography in the United States and the United kingdom. JAMA 2003; 290: 2129-37. doi: 10.1001/ jama.290.16.2129. 14570948.
7. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998; 16: 441-52.9469327.
8. Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P. Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol 2015; 1: 888-96. doi: 10.1001/jamaoncol.2015. 2510. 26291673.
9. Esserman L, Yau C. Rethinking the standard for ductal carcinoma in situ treatment. JAMA Oncol 2015; 1: 881-3. doi: 10.1001/jamaoncol.2015.2607. 26291410.
10. Cuzick J, Sestak I, Pinder SE, et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: Long-term results from the UK/ANZ DCIS trial. Lancet Oncol 2011; 12: 21-9. doi: 10.1016/S1470-2045(10)70266-7. 21145284.
11. Fisher ER, Land SR, Saad RS, et al. Pathologic variables predictive of breast events in patients with ductal carcinoma in situ. Am J Clin Pathol 2007; 128: 86-91. doi: 10.1309/ WH9LA543NR76Y29J. 17580274.
12. Kirsh VA, Chiarelli AM, Edwards SA, et al. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program. J Natl Cancer Inst 2011; 103: 942-50. doi: 10.1093/jnci/djr138. 21540443.
13. Henderson LM, Miglioretti DL, Kerlikowske K, Wernli KJ, Sprague BL, Lehman CD. Breast cancer characteristics associated with digital versus film-screen mammography for screen-detected and interval cancers. AJR Am J Roentgenol 2015; 205: 676-84. doi: 10. 2214/AJR.14.13904. 26295657.